SOURCE: HWI Global

May 25, 2011 17:53 ET

HWI Global CEO Discusses 2011 - 2012 Forecast; Confident About International Expansion

Company Announces 7:1 Forward Split; Symbol Change to HWIC

PITTSBURGH, PA--(Marketwire - May 25, 2011) - Deric Haddad, Chief Executive Officer of HWI Global, Inc. (OTCBB: IVTW), the Pittsburgh-based design-build clean-room firm, recently discussed a broad vision for the Company in his 2011 and 2012 forecast. HWI Global also announced a 7:1 forward split and a symbol change to HWIC.

"Our new patent-pending C3 SmartRoom Information Management Solution (C3) is the foundation of HWI's domestic and international expansion. The C3 system can be implemented to comply with a wide range of regulatory standards across many industries in the worldwide marketplace. Completely scalable, the C3 system expands combining real time management automation into one customized integrated tool for any life science, health care, or research laboratory.

"Our HWI team of experts designs and builds clean-room services in accordance with the Federal mandate USP 797, which requires hospital pharmacies to conduct compounded sterile preparations in ISO classified clean rooms. Although a U.S. mandate, we have many opportunities to show how our higher clean-room design-build standards can be applied to international projects as well. In the United Arab Emirates, HWI recently announced its plans to enter into a joint venture with two well-established Middle East firms; ASCI Ltd. a UAE-based construction management firm, and Energy International Corporation, a premier exporter of American-based industrial equipment. The Company is also currently involved in three other projects where USP 797 standards are being implemented, not by law but by preference.

"HWI previously thought that USP 797 was an American issue, so it seemed that at some point the market segment may slow down. Yet, what we are witnessing in the Middle East is that they are not only adapting the USP 797 architectural and construction standards, but they are also trending toward requiring the type of Level 3 reporting normally seen in bio-pharmaceutical production facilities. This is a perfect fit for our C3 system as it also validates compliance in accordance with Federal regulation 24CFR11, another Good Manufacturing Practice. While offering complete control, our C3 enables facilities to push their energy savings envelope.

"Creating this unique C3 patent-pending software application, further developing its OEM line of custom aseptic casework, and setting up the beginnings of an international joint venture that will expand HWI's operating base into six Middle East nations, has certainly come at a price. But, I am excited about what the future will bring as the Company diversifies its products and services, and will now be visible in so many locations.

"A significant amount of time and money has been directed toward HWI's intellectual property. We didn't go into this period of development with investment capital sitting in an account. Self-financing these endeavors has ultimately had a negative impact on our Q1- Q2 figures. Fortunately, the long-term payoff should justify the costs of R&D. Once our C3 system is installed in a UAE-based hospital pharmacy, we will have an HWI showcase in the Middle East marketplace; a showcase we expect to generate service-orientated, recurring contracts that give us repeat revenue, setting us apart from traditional clean-room design-builders."

About HWI Global

HWI Global is a leader in clean-room design engineering and construction, servicing clients in the Life Science, Health Science, Nanotechnology, Microelectronics and Aerospace industries. HWI Global and its network of subject matter experts (SME) -- from leading architects, engineers, facilities planners, and specialized installers -- effectively design and construct the most state-of-the-art clean environments in a "turnkey" fashion.

http://hwicleanrooms.com/

Safe Harbor Statements

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions. This press release shall not constitute an offer to issue or sell, or the solicitation of an offer to buy securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

IVTW is a member of EquityGroups The Investors Social Network

Contact Information